Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder
- 11 March 2024
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 133 (6) , 760-769
Abstract
Objective: To evaluate the efficacy and safety of a wearable, smartphone‐controlled, rechargeable transcutaneous tibial nerve stimulation (TTNS) device in patients with overactive bladder (OAB). Patients and Methods: This multicentre, prospective, single‐blind, randomised clinical trial included eligible patients with OAB symptoms who were randomly assigned to the stimulation group or sham group. The primary efficacy outcome was change from baseline in voiding frequency/24 h after 4 weeks of treatment. The secondary efficacy outcomes included changes in bladder diary outcomes (urgency score/void, nocturia episodes/day, micturition volume/void, and incontinence episodes/day), questionnaires on Overactive Bladder Symptom Score (OABSS), Patient Perception of Bladder Condition (PPBC), and American Urological Association Symptom Index Quality of Life Score (AUA‐SI‐QoL) at baseline and after 4 weeks of treatment. Device‐related adverse events (AEs) were also evaluated. Results: In the full analysis set (FAS), the mean ( sd) change of voiding frequency/24 h in the stimulation group and sham group at 4 weeks were −3.5 (2.9) and −0.6 (2.4), respectively ( P < 0.01). Similar results were obtained in the per‐protocol set (PPS): −3.5 (2.9) vs −0.4 (2.3) ( P < 0.01). In the FAS and PPS, micturition volume/void significantly improved at 4 weeks ( P = 0.01 and P = 0.02). PPBC improvement almost reached significance in the FAS ( P = 0.05), while it was significant in the PPS ( P = 0.02). In the FAS and PPS, AUA‐SI‐QoL significantly improved at 4 weeks in the two groups ( P < 0.01 and P < 0.01), whereas there were no significant differences in urgency score/void, nocturia episodes/day or OABSS between the groups. Also, no device‐related serious AEs were reported. Conclusions: The non‐invasive neuromodulation technique using the novel ambulatory TTNS device is effective and safe for treating OAB. Its convenience and easy maintenance make it a new potential home‐based treatment modality. Future studies are warranted to confirm its longer‐term efficacy.Keywords
Funding Information
- National Natural Science Foundation of China (82170792)
- Natural Science Foundation of Beijing Municipality (7222235)
- National Key Research and Development Program of China (2023YFC3606003)
This publication has 26 references indexed in Scilit:
- Efficacy of a novel wearable transcutaneous tibial nerve stimulation device on bladder reflex compared to implantable tibial nerve stimulation in catsInternational Urology and Nephrology, 2022
- Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled studyInternational Urology and Nephrology, 2022
- Inhibitory effects of a smartphone‐controlled wearable transcutaneous tibial nerve stimulation device on bladder reflexes in anesthetized catsNeurourology and Urodynamics, 2022
- Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson's disease: A randomized clinical trialNeurourology and Urodynamics, 2020
- Inhibitory effects of a minimally invasive implanted tibial nerve stimulation device on non-nociceptive bladder reflexes in catsInternational Urology and Nephrology, 2020
- Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trialNeurourology and Urodynamics, 2018
- Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladderClinical Autonomic Research, 2018
- Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trialEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
- An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunctionNeurourology and Urodynamics, 2009
- Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC StudyEuropean Urology, 2006